TRIM59 (Tripartite Motif-Containing 59) Expression in Pan-Cancer and Its Diagnostic and Prognostic Implications in Breast Cancer, Esophageal Cancer, Lung Squamous Cell Carcinoma, and Stomach Adenocarcinoma. [PDF]
Attaelmanan GA +10 more
europepmc +1 more source
Emerging biologic modalities for targeted protein degradation. [PDF]
Caldwell AG, Parmar H, Zhang X.
europepmc +1 more source
The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review. [PDF]
Yamada Y +8 more
europepmc +1 more source
Tripartite motif-containing protein 28 promotes drug resistance to bortezomib in gastric cancer through proteasome activity regulation. [PDF]
Xin L +7 more
europepmc +1 more source
The role of TRIM proteins in the pathogenesis of mycobacterium tuberculosis. [PDF]
Di Rienzo M +5 more
europepmc +1 more source
MYC-driven TRIM27 upregulation promotes prostate cancer progression by enhancing CANX ubiquitination and activating PI3K/AKT signaling. [PDF]
Wang Z, Ning J, Xu L, Cheng F.
europepmc +1 more source
TRIM11 is upregulated in esophageal cancer and promotes tumor progression through modulation of the β-catenin signaling pathway. [PDF]
Li W, Lan Q, Lu S, Dong W.
europepmc +1 more source
TRIM37 interacts with PTEN to promote progression of hepatocellular carcinoma cells by modulating AKT/GSK-3β/β-Catenin pathway. [PDF]
Wang Q, Zhang X, Zhang J.
europepmc +1 more source
TRIM52 Protects Against Doxorubicin-Induced Cardiac Inflammation, Oxidative Stress and Cardiac Injury. [PDF]
Zhang Z +8 more
europepmc +1 more source
TRIM62 promotes osteoarthritis progression by facilitating GPX4 ubiquitination and chondrocyte ferroptosis. [PDF]
Chen X, Zhang Y.
europepmc +1 more source

